(MedPage Today) — MADRID — Paclitaxel coating added no benefit to balloons and stents for endovascular peripheral arterial disease (PAD) intervention in the SWEDEPAD 1 and 2 trials — and in fact, researchers said they could not ignore a…
Source link : https://www.medpagetoday.com/meetingcoverage/esc/117247
Author :
Publish date : 2025-09-01 20:24:00
Copyright for syndicated content belongs to the linked Source.
